logo
Sign in

MRZM Stock Price, Chart, Stats & News

Marizyme, Inc.
Save

Marizyme, Inc. (MRZM) does not currently pay a dividend.

39,538
Market cap
Current P/E
Forward P/E

MRZM chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

Marizyme, Inc. is a life sciences company primarily engaged in bringing innovative medical technologies from development to market. Its offerings include DuraGraft, a unique single-application treatment administered during vascular and bypass surgeries, engineered to maintain the function and structure of the endothelium, along with other critical characteristics. The company is also progressing with various therapeutic products utilizing its Krillase protease-based platform.

Similar securities

Based on sector and market capitalization

Report issue